Opportunity Information: Apply for RFA AG 24 028
The National Institutes of Health (NIH) funding opportunity RFA-AG-24-028, titled "Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD (R01 Clinical Trial Not Allowed)," supports research that explains how immigration-related experiences shape health and aging outcomes over time. The central aim is to generate stronger behavioral and social science evidence on why health disparities emerge among first-generation immigrant populations in the United States, with a specific emphasis on middle-aged and older adults. The NOFO is especially interested in studies focused on Latino/a, Black, Asian, and other first-generation immigrant groups, and it encourages investigators to examine the mechanisms that operate at multiple levels, including structural forces, community contexts, and interpersonal relationships, across the life course.
A key theme of the announcement is the need to move beyond simple comparisons of immigrant versus non-immigrant health and instead identify the pathways that produce different outcomes as people age. The NOFO highlights structural mechanisms such as policies, legal status-related constraints, discrimination, labor market conditions, and access to healthcare and social services; community mechanisms such as neighborhood opportunity, social cohesion, ethnic enclaves, local resources, and exposure to environmental stressors; and interpersonal mechanisms such as family roles, caregiving expectations, social support, intergenerational relationships, and experiences of bias in daily interactions. Projects should be designed to show how these factors accumulate, interact, and change over time, ultimately influencing chronic disease risk, functional decline, mental health, disability, mortality, and broader measures of healthy aging.
In addition to general life course health and aging, the NOFO explicitly invites research that connects immigration to Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD). This includes work that clarifies whether and how immigration-related exposures across the life span affect cognitive aging, dementia risk, symptom recognition, diagnostic pathways, access to specialist care, caregiving burdens, and long-term outcomes. It also encourages applicants to tackle practical and scientific barriers in this area, such as gaps in available data, difficulties measuring immigration experiences consistently, and challenges in applying existing dementia research methods to immigrant and linguistically diverse populations. In other words, proposals can focus not only on substantive questions about risk and resilience, but also on the data infrastructure and methodological innovations needed to study these relationships well.
This is an R01 mechanism, meaning it is intended for mature, well-developed research projects rather than early exploratory work, and it is labeled "Clinical Trial Not Allowed," indicating that applicants should not propose clinical trial designs under this announcement. For investigators with high-risk/high-payoff ideas that are earlier stage and may not have extensive preliminary data, NIH points to a companion opportunity, RFA-AG-24-029, which uses the R21 Exploratory/Developmental Research Grant mechanism and is generally a better fit for more preliminary or proof-of-concept projects.
Eligibility is broad and includes many types of organizations and institutions. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofit organizations with and without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other entities. The NOFO also explicitly calls out additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based and community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. It also allows non-U.S. entities (foreign organizations), reflecting an openness to international collaborations or foreign-based applicants where appropriate.
Administratively, the opportunity is categorized as a discretionary grant in the health activity area under CFDA 93.866 and is sponsored by NIH, with an original closing date listed as 2023-11-03. The award ceiling is shown as $500,000, signaling that budgets are expected to be within that upper limit as defined by the announcement. Overall, NIH is looking for rigorous, innovative projects that can explain how immigration-related exposures and contexts shape aging trajectories and contribute to disparities, while also improving the tools and data approaches needed to study immigration, cognitive aging, and AD/ADRD in diverse immigrant populations.Apply for RFA AG 24 028
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2023-08-09.
- Applicants must submit their applications by 2023-11-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R34 Clinical Trial Optional)
Previous opportunity: Decision, Risk and Management Sciences
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 24 028
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 24 028) also looked into and applied for these:
| Funding Opportunity |
|---|
| Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R21 Clinical Trial Not Allowed) Apply for RFA AG 24 029 Funding Number: RFA AG 24 029 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed) Apply for RFA NS 24 007 Funding Number: RFA NS 24 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) Apply for RFA AG 24 041 Funding Number: RFA AG 24 041 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) Apply for RFA AG 24 042 Funding Number: RFA AG 24 042 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) Apply for PAR 24 029 Funding Number: PAR 24 029 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity Apply for 72065623APS00001 Funding Number: 72065623APS00001 Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $92,000,000 |
| Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) Apply for PAR 23 258 Funding Number: PAR 23 258 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) Apply for RFA AG 24 043 Funding Number: RFA AG 24 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed) Apply for RFA NS 24 027 Funding Number: RFA NS 24 027 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed) Apply for RFA NS 23 030 Funding Number: RFA NS 23 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) Apply for PA 23 290 Funding Number: PA 23 290 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) Apply for PA 23 291 Funding Number: PA 23 291 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Apply for PAR 23 274 Funding Number: PAR 23 274 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 046 Funding Number: RFA AG 24 046 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 162 Funding Number: RFA MH 24 162 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA AG 24 027 Funding Number: RFA AG 24 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional) Apply for RFA RM 23 012 Funding Number: RFA RM 23 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed) Apply for RFA HG 23 002 Funding Number: RFA HG 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional) Apply for RFA AG 24 031 Funding Number: RFA AG 24 031 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional) Apply for RFA AG 24 030 Funding Number: RFA AG 24 030 Agency: National Institutes of Health Category: Health Funding Amount: $2,750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 24 028", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
